30 Years of Research Experience!

Meeting the needs of our clients and the changing drug development environment

Learn more about our services

CMIC, Inc.

CMIC offers a unique blend of accomplished researchers, proprietary methodologies, and precision instrumentation.CMIC, Inc. (formerly JCL Bioassay USA) is a leading CRO and a provider specialized in bioanalytical services in support of TK/PK studies for pre-clinical and clinical developments. Located in Hoffman Estates, IL, the company provides cutting-edge capabilities and sophisticated expertise in bioanalytical method development, method validation/qualification and study sample analysis for small and large molecules. As a strategic drug development partner, CMIC helps sponsors to overcome challenges in bioanalysis with expertise, rapid turn-around-time and high quality services.

Our Mission is to contribute to high quality, efficient drug development and conduct science that contributes to the public welfare.

Our Vision is to become the most respected and trusted bioanalytical laboratories in the world.

Our Promise is to uphold a strict code of conduct, which is to:
• Conduct ourselves according to a strict business code of ethics
• Be professional scientists and continue to improve our expertise through extensive training and continuing education while performing as specialists in the industry
• Resolutely pursue our mission to contribute to high quality, efficient drug development

Our History - CMIC has over 30 years of experience in bioanalytical small molecule analysis and a reputation for excellence and a strong commitment to helping improve lives around the world. With dedication to the drug development market and continued success, CMIC has become a leading CRO in Japan and North America. Today, CMIC continues to grow and expand its facility and capabilities to meet the needs of our clients and the changing drug development environment.

Key Milestones


Contract bioanalytical services begin while part of Nighon Igaku Rinsho


Spun off from Nighon Igaku Rinsho and founded JCL Corp. with labs in Japan


JCL begins construction of facility in Hoffman Estates


Grand opening of JCL. First project agreement with major pharmaceutical


Implementation of Master Control quality document management system


Installation of Hamilton Microlab Star and Hamilton Nimbus Microlab


Laboratories standardize on Thermo Scientific Watson LIMS


Expansion of service offerings to include ligand-binding assays


Name change from JCL Bioassay to CMIC, Inc.


Lab Facility expansion and enhancement of service capabilities

Management Team

Kunio Momiyama - President and CEO

Mike Suga - President and CEO

Mike has been CMIC, Inc.’s business leader position since 2015, when former JCL Bioassay USA joined CMIC Group through acquisition. He together with the current leadership team also competed strategic facility investment in 2017, leveraged by CMIC’s new U.S. client base expansion after business integration. Mike is based in Chicago, while he also serves as Senior Vice President of CMIC HOLDINGS Co., Ltd., reporting directly into CMIC Group’s Tokyo Headquarters.

Prior to joining CMIC, Mike was the Deputy General Manager of GE Healthcare’s CT/MRI contrast media in-vivo diagnostics and PET/SPECT radio-phamarceuticals division in Japan, where he was the first employee soon after GE’s acquisition of former Amersham, and was responsible for establishing a new pharmaceutical operation reporing into GE Healthcare’s U.K. Headquarters. During GE, Mike was not only leading a number of pharmaceutical product and IP licensing (e.g.,Daiichi Sankyo, Sumitomo Chemical, Fujifilm) and regulatory authority (PMDA/MHLW) negotiations, but also was heavily iolved in clinical rials (GCP) and CMC deleopment (GMP) both globally (Phase III~Post-approval) and regionally(Asian-Caucasion bridging Phase I~II).

Mike started his 30-year’s professional career as tissue culture and genomics scientist at JT (now a.k.a. Akros) genetic engineering lab, and later spent five years in New York and San Francisco as JT’s recombinant DNA business development manager. Mike earned bachelor and master degrees in agricultural biosciences from University of Tokyo. He also completed GE’s company internal executive training at its Crotonville, New York main campus.

Jenny Lin - VP Operations and CSO

Jenny Lin - Chief Operating Officer (Test Facility Manager)

Approximately 25 years executive/lab management experience for bioanalytical and analytical laboratory operations in support of drug discovery, pre-clinical and clinical drug development; Proficient in GLP, GMP, GCP, OECD, ICH and 21 CFR part 11 regulations; Proficient in business strategic planning and execution; Expertise includes building organizational quality system, staff training, bioanalytical/analytical method development/validation; bioanalytical sample analysis; analytical development for CMC submission; chromatography purification; stability studies; reference standard certification; Directly lead and participate in CMC and bioanalytical development for numerous pre-clinical and clinical trials in support of IND/NDA filings.

Jenny has been a selected member for Global Bioanalysis Consortium (GBC) making recommendations for global Bioanalysis harmonization. She serves as editorial board member for peer reviewed journal and chair for international conferences. She is author and coauthor for more than 30 publications, white papers and presentations. She is the inventor of 7 issued US patents. Jenny earned her BS in Analytical Chemistry at Peking University and her MS in Medicinal Chemistry at University of Connecticut. Jenny is a member of the American Society of Mass Spectrometry (ASMS), American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), National Association of Professional Woman (NAPW) and Global CRO Council (GCC).

Denise Waschick - HR/ Admin. Manager

Denise Waschick - HR/ Admin. Manager

Denise Washick serves as a Sr. Manager of Human Resource, Administrative, and Process Improvement to guide and manage the overall provision of Human Resources services, policies, and programs, oversee the administration team, and operate as a deputy of Senior Management to improve and monitor functional areas such as Accounting and Business Development. She originates and leads Human Resources practices and objectives to provide an employee-oriented; high performance culture that emphasizes empowerment, quality, productivity and standards; goal attainment, and the recruitment and ongoing development of a superior workforce. Major areas of responsibility include recruiting/staffing, indoctrination and training, programs for HR related regulatory compliance, employee relations, compensation, benefits, safety and health, employee communications and expatriate relations.

Denise is an accomplished business professional with over 11 years of leadership experience directing aspects of human resource management, payroll management, administrative management and financial oversight. She obtained her Bachelor’s of Arts degree in Psychology and is certified as a Professional in Human Resource (PHR). She is a member of the Society for Human Resource Management (SHRM).

We are committed to working closely with you throughout the development process.